6,678 trials
Asthma
Primary: Rate of Asthma Exacerbations Per Year — 0.69; 0.82 Adjusted annualized exacerbations — p=0.048
Percutaneous Coronary Intervention
Primary: Concentration of Pharmacodynamics — 142.5; 210 platelet reaction units
Lumbar Post-Laminectomy Syndrome · Chronic Low Back Pain · Vertebral Compression Fracture
Primary: Change in Numerical Rating Scale Pain Scores (NRS) With Activity — 8.40; 8.00; 4.13; 4.19 Score on a scale
Primary Immunodeficiency Diseases (PID)
Primary: Safety: Number of Participants With Any Severe Related Treatment-emergent Adverse Events (TEAEs) Per Infusion (Excluding Infections) — 1; 0 Participants
Pain
Primary: Cmax of Oxycodone Oral Solution. — 5.92 mg/kg
Apnea · Apnea Neonatal · Prematurity
Primary: Occurrence of Apnea — 25; 12; 80; 104 Participants — p=0.0104
Morbid Obesity · High BMI
Primary: The Amount of Opioid Consumption During and After Procedure — 26.3; 27.1; 5.49; 5.52 mg IV morphine equivalents
Lumbar Spine Degeneration
Primary: Postoperative Opioid Utilization — 4.82; 9.17 morphine milligram equivalents
Thrombocytopaenia
Primary: Number of Participants With Adverse Events (AEs) — 7; 12; 6; 7 Participants
Rosacea · Papulopustular Rosacea
Primary: Improvement of the Inflammatory Lesions (Papules, Pustules, Nodules), Erythema, and Telangiectasia of Rosacea as Assessed by the Investigator's Global Assessment (IGA)…
Intrauterine Device Expulsion
Primary: Number of Participants With Expulsion of IUD — 54; 0 Participants
Pain
Primary: Neonatal Facial Coding System Score — 4.6; 3.9; 8.3; 8 score on a scale
Pediatric Congenital Heart Disease
Primary: Composite Image Quality Score Among 7 Anatomical Structures. — 3.9; 2.7 score on a scale
Nausea · Vomiting · Satisfaction
Primary: Number of Patients With Nausea — 40; 39; 46 Participants — p=0.98
Safety · Adverse Event Following Immunisation · Birth Outcomes
Primary: Number of Pregnant Women Vaccinated With RIV4 Versus IIV4 With Adverse Birth Outcomes — 17; 21 Participants — p=<0.0001